Target intelligence / Profile preview

Regulator of nonsense transcripts 1 (UPF1) (UPF1)

Target
UPF1
Molecular classification
Enzyme, RNA helicase, ATPase, Phosphoprotein
01

Overview

Regulator of nonsense transcripts 1 (UPF1) is a highly conserved ATP-dependent RNA helicase that serves as the central engine of the nonsense-mediated mRNA decay (NMD) pathway (UniProt P30801). NMD is a critical cellular quality control mechanism that identifies and degrades messenger RNAs (mRNAs) harboring premature termination codons (PTCs), preventing the synthesis of potentially deleterious truncated proteins. The activity of UPF1 is tightly regulated by a cycle of phosphorylation and dephosphorylation, primarily mediated by the kinase SMG1 and the phosphatase complex PP2A. In many genetic diseases, such as cystic fibrosis and Duchenne muscular dystrophy, NMD is considered a therapeutic target because it degrades mRNAs that could otherwise produce partially functional proteins if allowed to persist. In oncology, NMD inhibition is an emerging strategy to enhance the expression of tumor-specific neoantigens or to restore the expression of mutated tumor suppressor genes. Small molecules like Amlexanox and experimental inhibitors like NMDI-1 target this pathway to modulate RNA stability for clinical benefit.

Other names
UPF1 RNA helicase and ATPaseRENT1Nonsense mRNA reducing factor 1SMG2ATP-dependent RNA helicase UPF1HUPF1
02

Mechanism of action

Inhibition of the NMD machinery to prevent the degradation of mRNAs containing premature termination codons (PTCs), thereby stabilizing transcripts to allow for the translation of truncated or full-length proteins, or to increase neoantigen presentation in tumors.

03

Biological functions

Nonsense-mediated decayRNA surveillancemRNA degradationDNA replication stress responseTelomere maintenanceStaufen-mediated mRNA decayHistone mRNA degradation
04

Disease associations

CancerCystic fibrosisDuchenne muscular dystrophySpinal muscular atrophyBeta-thalassemiaNeurodegenerative disease
05

Safety considerations

Global disruption of mRNA quality controlPotential accumulation of toxic truncated proteinsOff-target effects on DNA damage repair pathwaysPotential for genomic instability due to telomere maintenance interferenceGeneral cellular toxicity from broad RNA metabolism alteration
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

PTC-containing mRNA levelsUPF1 phosphorylation statusTruncated protein expression levelsSMG1 activity levels

Beyond the preview

Go deeper on Regulator of nonsense transcripts 1 (UPF1) (UPF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regulator of nonsense transcripts 1 (UPF1) (UPF1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call